Initially the market thought Biogen's Alzheimers trial results were good but after the readout of the data there seems to be more questions...
This could impact ACW SP possitively.
DYOR
https://uk.finance.yahoo.com/news/biogen-eisai-sink-much-awaited-150700734.html?.tsrc=applewf
- Forums
- ASX - By Stock
- renewed interest
Initially the market thought Biogen's Alzheimers trial results...
Featured News
Add ACW (ASX) to my watchlist
|
|||||
Last
7.1¢ |
Change
-0.002(2.74%) |
Mkt cap ! $201.9M |
Open | High | Low | Value | Volume |
7.6¢ | 7.7¢ | 7.0¢ | $446.3K | 6.108M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 223547 | 7.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.3¢ | 138588 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 277062 | 0.071 |
5 | 221927 | 0.070 |
4 | 601218 | 0.069 |
2 | 350000 | 0.068 |
2 | 150000 | 0.067 |
Price($) | Vol. | No. |
---|---|---|
0.072 | 35000 | 1 |
0.073 | 100000 | 1 |
0.074 | 115700 | 2 |
0.075 | 418905 | 4 |
0.076 | 166726 | 3 |
Last trade - 12.05pm 10/07/2024 (20 minute delay) ? |
Featured News
ACW (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online